Last reviewed · How we verify

NCT05016674

Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat

Withdrawn NA Last updated 5 September 2024
What this trial tests

NA trial testing LipoLife system in Laser Assisted Liposuction. Withdrawn.

Timeline
21 July 2021
Primary endpoint
1 February 2023
1 May 2023

Quick facts

Lead sponsorAlma Lasers
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date21 July 2021
Primary completion1 February 2023
Estimated completion1 May 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Alma Lasers

Who can join

Adults 18 to 70, any sex, with Laser Assisted Liposuction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-center, prospective, open-label study. The study aims to assess the structure and viability of fat collected during the LipoLife liposuction procedure

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of LipoLife system

Trials testing the same drug.

Other Alma Lasers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05016674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing